These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15660713)

  • 21. Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine.
    Kraus RP
    Depression; 1996; 4(2):92-4. PubMed ID: 9160648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin syndrome: a complex but easily avoidable condition.
    Dvir Y; Smallwood P
    Gen Hosp Psychiatry; 2008; 30(3):284-7. PubMed ID: 18433663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptoms of agitated depression and/or akathisia.
    Peitl MV; Prološčić J; Blažević-Zelić S; Skarpa-Usmiani I; Peitl V
    Psychiatr Danub; 2011 Mar; 23(1):108-10. PubMed ID: 21448111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment of depression with paroxetine in psychiatric practice in Germany: the possibilities and current limitations of drug monitoring.
    Zaninelli R; Meister W
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):9-20. PubMed ID: 9035223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunctive aripiprazole for bupropion-resistant major depression.
    Sokolski KN
    Ann Pharmacother; 2008 Jul; 42(7):1124-9. PubMed ID: 18492784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olanzapine-induced neutropenia: mechanism and treatment.
    Duggal HS; Gates C; Pathak PC
    J Clin Psychopharmacol; 2004 Apr; 24(2):234-5. PubMed ID: 15206675
    [No Abstract]   [Full Text] [Related]  

  • 27. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
    Krol DG; Nolen WA
    Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bupropion-induced hypomania in a patient with unipolar depression.
    Hussain H; Butt MA
    Aust N Z J Psychiatry; 2008 Aug; 42(8):746. PubMed ID: 18622783
    [No Abstract]   [Full Text] [Related]  

  • 29. Seizure during combination of trimipramine and bupropion.
    Enns MW
    J Clin Psychiatry; 2001 Jun; 62(6):476-7. PubMed ID: 11465529
    [No Abstract]   [Full Text] [Related]  

  • 30. Withdrawal hypomania associated with paroxetine.
    Landry P; Roy L
    J Clin Psychopharmacol; 1997 Feb; 17(1):60-1. PubMed ID: 9004064
    [No Abstract]   [Full Text] [Related]  

  • 31. Ileus as a possible result of bupropion in an elderly woman.
    Kales HC; Mellow AM
    J Clin Psychiatry; 1999 May; 60(5):337. PubMed ID: 10362444
    [No Abstract]   [Full Text] [Related]  

  • 32. Paroxetine and amitriptyline in the treatment of depression in general practice.
    Christiansen PE; Behnke K; Black CH; Ohrström JK; Bork-Rasmussen H; Nilsson J
    Acta Psychiatr Scand; 1996 Mar; 93(3):158-63. PubMed ID: 8739658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medication associated long QT syndrome].
    Bruggisser M; Rätz Bravo A; Bodmer M
    Praxis (Bern 1994); 2009 Dec; 98(24):1409-15; quiz 1415. PubMed ID: 19953465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
    Citrome L
    Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.
    Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I
    Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Withdrawal symptoms associated with paroxetine discontinuation in a nine-year-old boy.
    Diler RS; Tamam L; Avci A
    J Clin Psychopharmacol; 2000 Oct; 20(5):586-7. PubMed ID: 11001250
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression.
    Sagud M; Pivac N; Mustapic M; Nedic G; Peles AM; Kramaric M; Jakovljevic M; Muck-Seler D
    Psychopharmacology (Berl); 2008 May; 197(4):683-5. PubMed ID: 18246328
    [No Abstract]   [Full Text] [Related]  

  • 38. Paroxetine in depressed adolescents with intellectual disability: an open label study.
    Masi G; Marcheschi M; Pfanner P
    J Intellect Disabil Res; 1997 Jun; 41 ( Pt 3)():268-72. PubMed ID: 9219077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder.
    Nakaaki S; Murata Y; Furukawa TA
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):370. PubMed ID: 18588607
    [No Abstract]   [Full Text] [Related]  

  • 40. Two cases of burning mouth syndrome treated with olanzapine.
    Ueda N; Kodama Y; Hori H; Umene W; Sugita A; Nakano H; Yoshimura R; Nakamura J
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):359-61. PubMed ID: 18588600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.